Infectious Disease
Helicobacter Pylori
0
Pipeline Programs↗
13
Active Trials↗
2
Companies Involved↗
Helicobacter Pylori is an early-stage landscape with 0 programs across 2 companies. The most active players are RedHill Biopharma Limited, Takeda.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
90
clinical trials
Completed49 · 54%
Unknown status24 · 27%
Recruiting5 · 6%
Not yet recruiting4 · 4%
Active, not recruiting3 · 3%
Withdrawn3 · 3%
Other2 · 2%
Clinical Trials
Trial Activity
90 trials
A Pilot Prospective Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Preclinical·NCT06871579·25 enrolled
Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy
Active, not recruiting·TThe First Affiliated Hospital of Nanchang University·Phase 4·NCT05749081·324 enrolled
Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori
Not yet recruiting·NNanjing First Hospital, Nanjing Medical University·Phase 4·NCT06412640·268 enrolled
Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Not yet recruiting·SSixth Affiliated Hospital, Sun Yat-sen University·Phase 3·NCT06760065·316 enrolled
Low-Dose Amoxicillin Dual-Therapy Combined with Licorice and Lotus Root Powder Helicobacter Pylori Treatment
Not yet recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·N/A·NCT06881524·374 enrolled
Keverprazan Combined with Amoxicillin for the Treatment of Helicobacter Pylori
Not yet recruiting·KKey Laboratory for Gastrointestinal Diseases of Gansu Province·N/A·NCT06851468·264 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)